RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Breast Cancer: Updated Overall Survival Results from EMILIA
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 15
SP 13
OP 13
DO 10.1177/155989771215009
UL http://mdc.sagepub.com/content/12/15/13.1.abstract
AB This article reports on updated study results of an Open-Label Study of Trastuzumab Emtansine versus Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer [EMILIA; NCT00829166] showing that progression-free survival and overall survival significantly improved in patients with breast cancer treated with trastuzumab emtansine compared with capecitabine plus lapatinib.